China CDC Begins Pilot Survey To Identify New HIV Types
This article was originally published in PharmAsia News
Executive Summary
China's Center for Disease Control and Prevention has begun a pilot program aimed at identifying the source of new HIV outbreaks that occur in three provinces of the country through Sept. 30. Under the survey program, the CCDC aims to track the history of the disease in HIV-positive patients and the differences between new outbreaks and previous ones. Health officials hope to use the information to help in creating an AIDS-prevention strategy. (Click here for more
You may also be interested in...
Sanofi Skates To Where The Puck Is With Immunology
The French drugmaker has not abandoned oncology but has made it very clear that immunology and inflammation is the priority for its R&D euros.
Pipeline Watch: Five Approvals And 23 Phase III Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Lack Of Industry Involvement In EU HTA Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.